Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Intolerance”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Testing effectiveness (Phase 2)Study completedNCT01271777
What this trial is testing

Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity

Who this might be right for
Insulin ResistanceAbdominal Obesity
Genfit 22
Not applicableStudy completedNCT03884920
What this trial is testing

Glucose Tolerance and Prevention of Diabetes Mellitus Type 2 by Polyherbal Formulation

Who this might be right for
Diabetes MellitusPre Diabetes
Islamia University of Bahawalpur 57
Post-approval studies (Phase 4)Study completedNCT02060084
What this trial is testing

Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm

Who this might be right for
Disorder of Stomach Function and Feeding Problems in NewbornFeeding and Eating Disorders of Childhood
Wang Hua 60
Testing effectiveness (Phase 2)Study completedNCT05803772
What this trial is testing

Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test

Who this might be right for
PreDiabetesGlucose Tolerance Impaired
Aphaia Pharma US LLC 31
Large-scale testing (Phase 3)Study completedNCT00001016
What this trial is testing

A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT04946045
What this trial is testing

Feeding Readiness and Oral Feeding Success in Preterm Infants

Who this might be right for
PretermFeeding BehaviorEnteral Feeding Intolerance
Pamukkale University 60
Not applicableStudy completedNCT03506581
What this trial is testing

Dysfunctional Adiposity and Glucose Impairment

Who this might be right for
Body CompositionVisceral ObesityCarbohydrate Intolerance+5 more
Clinica Universidad de Navarra, Universidad de Navarra 853
Testing effectiveness (Phase 2)UnknownNCT04662866
What this trial is testing

Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose

Who this might be right for
Impaired Glucose ToleranceInsulin SensitivityGlucose Metabolism Disorders
Oslo University Hospital 64
Not applicableLooking for participantsNCT07517406
What this trial is testing

Glycemic Markers for Predicting Gestational Diabetes in Pregnant Women With Previous Bariatric Surgery

Who this might be right for
Gestational Diabetes Mellitus (GDM)Pregnancy ComplicationsHistory of Bariatric Surgery
Burak Deniz Aydoğdu 84
Testing effectiveness (Phase 2)Study completedNCT02095873
What this trial is testing

Healthy Aging Through Functional Food

Who this might be right for
Glucose IntoleranceAortic StiffnessVasodilation
University of Warwick 32
Testing effectiveness (Phase 2)Study completedNCT05823896
What this trial is testing

ImPROving Quality of LIFe in the Long COVID Patient

Who this might be right for
Post-COVID-19 SyndromeLong COVIDLong Covid19+7 more
Karolinska Institutet 219
Large-scale testing (Phase 3)Looking for participantsNCT07342478
What this trial is testing

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

Who this might be right for
CLL / SLLCLL (Chronic Lymphocytic Leukemia)CLL, Refractory+5 more
Newave Pharmaceutical Inc 306
Not applicableStudy completedNCT06628869
What this trial is testing

The Effects of Oral Fructanase Administration on Gastrointestinal Symptoms After Inulin Challenge in Healthy Adults

Who this might be right for
Digestive HealthGastrointestinal HealthFODMAP Intolerance+1 more
BIO-CAT, Inc. 30
Not applicableStudy completedNCT02254317
What this trial is testing

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance

Who this might be right for
Impaired Glucose Tolerance
Clinical Nutrition Research Center, Illinois Institute of Technology 16
Not applicableStudy completedNCT01374919
What this trial is testing

Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia

Who this might be right for
Iron Deficiency Anemia
Auerbach Hematology Oncology Associates P C 60
Not applicableUnknownNCT01865409
What this trial is testing

Effect of Kangaroo Care on Heart Rate Variability

Who this might be right for
ImmaturityOral IntolerancePostnatal Adaptation
Fatih University 30
Not applicableLooking for participantsNCT06609213
What this trial is testing

Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS

Who this might be right for
Amyotrophic Lateral SclerosisGastrointestinal IntoleranceEnteral Nutrition Therapy
Andrea Charvet 22
Not applicableStudy completedNCT02702245
What this trial is testing

Effects of Two Doses of Thylakoids on OGTT

Who this might be right for
Glucose Intolerance
Region Skane 21
Not applicableLooking for participantsNCT04008147
What this trial is testing

Hepcidin and Glucose Metabolism

Who this might be right for
Iron Deficiency Anemia of PregnancyIron Metabolism DisordersGlucose Intolerance+1 more
Swiss Federal Institute of Technology 30
Testing effectiveness (Phase 2)Study completedNCT01068860
What this trial is testing

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Who this might be right for
Type 2 Diabetes MellitusImpaired Glucose Tolerance
Novartis 246
Next Page